Literature DB >> 8576839

A general conceptual model for non-steady state pharmacokinetic/pharmacodynamic data.

D Verotta1, L B Sheiner.   

Abstract

Mesh：

Year:  1995        PMID： 8576839     DOI： 10.1007/bf02353780

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  4 in total

1.  Kinetics of interaction between drugs and biological systems.

Authors:  G Segre
Journal:  Farmaco Sci       Date:  1968-10

2.  Comparison of four basic models of indirect pharmacodynamic responses.

Authors:  N L Dayneka; V Garg; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1993-08

3.  A model eliciting transient responses.

Authors:  E B Ekblad; V Licko
Journal:  Am J Physiol       Date:  1984-01

4.  Semiparametric analysis of non-steady-state pharmacodynamic data.

Authors:  D Verotta; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1991-12
  4 in total
  18 in total

1.  Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives.

Authors:  H Derendorf; B Meibohm
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

2.  Volterra series in pharmacokinetics and pharmacodynamics.

Authors:  Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-10       Impact factor: 2.745

3.  Collapsing mechanistic models: an application to dose selection for proof of concept of a selective irreversible antagonist.

Authors:  Matthew M Hutmacher; Debu Mukherjee; Kenneth G Kowalski; David C Jordan
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-08       Impact factor: 2.745

Review 4.  Pharmacokinetic-pharmacodynamic modelling: history and perspectives.

Authors:  Chantal Csajka; Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-01-11       Impact factor: 2.745

5.  Modelling response time profiles in the absence of drug concentrations: definition and performance evaluation of the K-PD model.

Authors:  P Jacqmin; E Snoeck; E A van Schaick; R Gieschke; P Pillai; J-L Steimer; P Girard
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-10-19       Impact factor: 2.745

6.  Characterization of the dose-dependent time of peak effect in indirect response models.

Authors:  A Majumdar
Journal:  J Pharmacokinet Biopharm       Date:  1998-04

Review 7.  Expanding clinical applications of population pharmacodynamic modelling.

Authors:  C Minto; T Schnider
Journal:  Br J Clin Pharmacol       Date:  1998-10       Impact factor: 4.335

8.  The time of maximum effect for model selection in pharmacokinetic-pharmacodynamic analysis applied to frusemide.

Authors:  M Wakelkamp; G Alván; G Paintaud
Journal:  Br J Clin Pharmacol       Date:  1998-01       Impact factor: 4.335

9.  Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.

Authors:  Christopher Louizos; Jaime A Yáñez; M Laird Forrest; Neal M Davies
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

10.  Brain microdialysis and PK/PD correlation of pregabalin in rats.

Authors:  M R Feng; D Turluck; J Burleigh; R Lister; C Fan; A Middlebrook; C Taylor; T Su
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Jan-Jun       Impact factor: 2.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.